Claris Lifesciences Gets U.S. FDA nod for Flumazenil Injection
A scientist prepares a syringe before carrying out manual patch technique on cells in the laboratory (Photographer: Krisztian Bocsi/Bloomberg)

Claris Lifesciences Gets U.S. FDA nod for Flumazenil Injection

Drug firm Claris Lifesciences has received approval from the U.S. health regulator for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the America marke...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.